Activation of progelatinase B (MMP-9) by gelatinase A (MMP-2)
- PMID: 7780967
Activation of progelatinase B (MMP-9) by gelatinase A (MMP-2)
Abstract
The M(r) 72,000 (MMP-2; gelatinase A) and M(r) 92,000 (MMP-9; gelatinase B) gelatinases are two members of the family of matrix metalloproteinases (MMPs). These proteinases are thought to play a critical role in tumor cell invasion and are frequently coexpressed in human cancers. Gelatinases are secreted in a latent inactive form, and their conversion to the active species can be accomplished by other proteolytic enzymes, including other MMPs. We report herein that organomercurial or plasma membrane-activated M(r) 72,000 gelatinase A activates progelatinase B to an M(r) 82,000 active form in a process inhibited by tissue inhibitor of metalloproteinase (TIMP)-1 and TIMP-2. Progelatinase B activation was accomplished by the two active species of gelatinase A, the M(r) 62,000 and M(r) 45,000 forms, generated after plasma membrane or organomercurial activation of TIMP-2-free progelatinase A. The M(r) 45,000 species of gelatinase A lacks both the NH2-terminal profragment and the COOH-terminal domain known to play a role in plasma membrane activation and the regulation of TIMP-2 inhibition. These results suggest a novel mechanism of activation of progelatinase B mediated by gelatinase A species that may be localized in the surface of tumor cells and enhance matrix degradation during cancer metastasis.
Similar articles
-
Tissue inhibitor of metalloproteinases-4 inhibits but does not support the activation of gelatinase A via efficient inhibition of membrane type 1-matrix metalloproteinase.Cancer Res. 2001 May 1;61(9):3610-8. Cancer Res. 2001. PMID: 11325829
-
Sequence motifs of tissue inhibitor of metalloproteinases 2 (TIMP-2) determining progelatinase A (proMMP-2) binding and activation by membrane-type metalloproteinase 1 (MT1-MMP).Biochem J. 2003 Jun 15;372(Pt 3):799-809. doi: 10.1042/BJ20021573. Biochem J. 2003. PMID: 12630911 Free PMC article.
-
Differential expression of membrane-type matrix metalloproteinase and its correlation with gelatinase A activation in human malignant brain tumors in vivo and in vitro.Cancer Res. 1996 Jan 15;56(2):384-92. Cancer Res. 1996. PMID: 8542596
-
Membrane-type matrix metalloproteinases (MT-MMPs) in cell invasion.Thromb Haemost. 1997 Jul;78(1):497-500. Thromb Haemost. 1997. PMID: 9198203 Review.
-
Cell surface activation of progelatinase A (proMMP-2) and cell migration.Cell Res. 1998 Sep;8(3):179-86. doi: 10.1038/cr.1998.18. Cell Res. 1998. PMID: 9791731 Review.
Cited by
-
Matrix metalloproteinase activity and osteoclasts in experimental prostate cancer bone metastasis tissue.Am J Pathol. 2005 Apr;166(4):1173-86. doi: 10.1016/S0002-9440(10)62337-1. Am J Pathol. 2005. PMID: 15793297 Free PMC article.
-
Increased expression of MMP9 is correlated with poor prognosis of nasopharyngeal carcinoma.BMC Cancer. 2010 Jun 9;10:270. doi: 10.1186/1471-2407-10-270. BMC Cancer. 2010. PMID: 20534121 Free PMC article.
-
The role of matrix metalloproteinase genes in glioma invasion: co-dependent and interactive proteolysis.J Neurooncol. 2001 Jun;53(2):213-35. doi: 10.1023/a:1012280925031. J Neurooncol. 2001. PMID: 11716072 Review.
-
Decreased ratios of matrix metalloproteinases to tissue-type inhibitors in cerebrospinal fluid in sporadic and hereditary cerebral amyloid angiopathy.Alzheimers Res Ther. 2023 Jan 30;15(1):26. doi: 10.1186/s13195-023-01171-3. Alzheimers Res Ther. 2023. PMID: 36717932 Free PMC article.
-
Protein tyrosine phosphatase controls breast cancer invasion through the expression of matrix metalloproteinase-9.BMB Rep. 2013 Nov;46(11):533-8. doi: 10.5483/bmbrep.2013.46.11.053. BMB Rep. 2013. PMID: 24152909 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous